Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a probiotic cut Kids' diarrhea short? new trial aims to find out

NCT ID NCT07342101

Disease control Sponsor: Eskisehir Osmangazi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 1 time

Summary

This study tests whether adding a probiotic called Lacticaseibacillus rhamnosus GG to standard care (like rehydration fluids) can shorten the duration of acute infectious diarrhea in children. About 480 kids aged 1 month to 10 years in Turkey will take part. Half will get the probiotic plus standard care, and half will get standard care alone. Families will track stool frequency and consistency for 10 days.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lacticaseibacillus rhamnosus GG (a probiotic, 5 billion CFU twice daily for 6 days)
What this could lead to
If it works, this could provide a simple, safe way to shorten diarrhea in children and reduce hospital stays.
What could go wrong
This is an early-stage trial with no phase, and results may not apply to all children. The probiotic may not work better than standard care alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 480 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

2 to 10 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 1 month to 10 years presenting with acute infectious diarrhea (for S. boulardii group) * Children aged 2 to 10 years presenting with acute infectious diarrhea (other probiotics or synbiotics groups) * Onset of diarrhea symptoms within the last 48 hours. * Parental/legal guardian consent obtained. Exclusion Criteria: * Use of any probiotics or biotic formulations within the past 8 weeks. * Use of antibiotics in the last 8 weeks. * Presence of chronic diseases (e.g., diabetes, congenital heart disease, immunodeficiencies). * Previous gastrointestinal surgical procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute infectious diarrhoea in children are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diarrheal disease dysentery

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute infectious diarrhoea in children

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Eskisehir Osmangazi University Faculty of Medicine

    RECRUITING

    Eskişehir, Turkey (Türkiye)

  • Prof.Dr. Cemil Taşçıoğlu City Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)

  • Sisli Hamidiye Etfal Training and Research Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)